RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer
Anne T. Schneider(Düsseldorf University Hospital), Tom Luedde(Heinrich Heine University Düsseldorf), René H. Tolba(RWTH Aachen University), Christian Preisinger(RWTH Aachen University), Maria Feoktistova(RWTH Aachen University), Peter Schemmer(Heidelberg University), Fabian Benz(RWTH Aachen University), Thomas Longerich(Heidelberg University), Jessica Zucman‐Rossi(Inserm), Sven H. Loosen(Düsseldorf University Hospital), Jérémie Gautheron(Inserm), Diana Panayotova‐Dimitrova(RWTH Aachen University), Ueli Nachbur(The University of Melbourne), Mihael Vucur(Düsseldorf University Hospital), Frank Tacke(Charité - Universitätsmedizin Berlin), Ulf P. Neumann(RWTH Aachen University), Christoph Roderburg(Universitätsklinikum Aachen), Mark Luedde(Christian-Albrechts-Universität zu Kiel), Sanchari Roy(RWTH Aachen University), Martin Leverkus(RWTH Aachen University), Markus W. Büchler(Heidelberg University), Christian Trautwein(TUM Klinikum)
Cited by 163
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
|Nature Genetics|2015|1.8k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k